ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 209835 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 209835; 2) Community: the network communities that were significantly associated with the response to NSC 209835; 3) Molecule: the relationships between components within communities and NSC 209835; 4) MDR: the compounds that were significantly associated with the NSC 209835.

NSC Compound Enrichment Correlation
NSC 705814 Null 0.0286383688883668 0.5324243
NSC 70931 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo- 0.0286383688883668 -0.0045117384
NSC 710587 Null 0.0286383688883668 -0.14729403
NSC 78714 Clothixamide maleate (USAN) 0.0286383688883668 0.12758262
NSC 100071 component of Halotex 0.0339770934764509 -0.097370919
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0339770934764509 -0.09542953
NSC 150311 2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- 0.0339770934764509 -0.32932055
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0339770934764509 0.37750521
NSC 180973 Tamoxifen citrate 0.0339770934764509 -0.12952079
NSC 295501 Camptothecin Derivative 0.0339770934764513 0.17700931
Total:49  Current:26    [First] [Prev] [Next] [Last]